Evaluating the Scientific Evidence for Potential Reduced-Risk Tobacco Products |
|
Biological Effects Assessment (BEA) Committee |
|
Meeting #3: November 29-30, 2005 |
PRELIMINARY AGENDA |
|
Day One: November 29 (8 a.m. - 6 p.m.) |
|
|
Executive Session (8 a.m. - 6 p.m.) |
|
I. |
Opening Remarks and Review of Agenda |
|
II. |
Animal Models Wrap-up |
|
III. |
Accord Case Study |
|
|
LUNCH
|
|
IV. |
Wrap-up of Human Biomarkers
|
|
|
Day Two: November 30 (8 a.m. - 3 p.m.) |
|
|
Executive Session (8 a.m. - 3 p.m.) |
|
I. |
Weight of Evidence Approaches |
|
II. |
Integration of Cigarette Smoke Toxicants, Genotoxicity and Cytotoxicity, Animal and Human
Biomarker Data for Assessing Potential Reduced-Risk
|
|
|
|
LUNCH
|
|
|
III. |
Discussion of BEA report outline and work products
|
Adjourn (3 p.m.) |